By ThinkSabio #ThinkSabio Latest News
Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs) Enrollment Completed for Phase 3 HARMONi Trialin 2L+ EGFRm Advanced NSCLC
TopLine Data Expected Mid-2025.